Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.

about

Peptides and Drug Delivery.Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.A review on core-shell structured unimolecular nanoparticles for biomedical applications

P2860

Q47590591-7FD25F7E-03E0-468F-97E9-52C313E016D3 Q52708818-DAF3E756-CB93-4E51-95CD-1ECC23BFBA68 Q57179221-ADECA64C-A05E-4B96-BB4E-55C8E929009F

P2860

Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.

Item

http://www.wikidata.org/entity/Q36211730

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@ast

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@en

type

Item

label

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@ast

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@en

prefLabel

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@ast

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@en

P1476

Carboplatin-Complexed and cRGD ...... rgeted Ovarian Cancer Therapy.

@en

P2093

Guojun Chen

http://www.w3.org/2001/XMLSchema#string

Liwei Wang

http://www.w3.org/2001/XMLSchema#string

Shaoqin Gong

http://www.w3.org/2001/XMLSchema#string

Yuyuan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

The status of platinum anticancer drugs in the clinic and in clinical trials

Nanoparticle therapeutics: an emerging treatment modality for cancer

Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.

Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.

cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.

Retinoids and ovarian cancer.

Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging

Mechanisms of resistance to cisplatin.

P31

scholarly article

P356

10.1002/MABI.201600292

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27911475

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

nanoparticle

P932

5914160

http://www.w3.org/2001/XMLSchema#string

Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.

about

P2860

P2860

Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932